Impact Factor
3.63
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.77
635 total citations
h5-index
31
h5 depth signal
Cited share
82.5%
146 of 177
Total citations
635
Citation footprint
Metric signal
3.16
External metric anchor
Self-citation
1.1%
7 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
527
United States
495
Japan
121
Germany
72
United Kingdom
69
Citing Fields of Research
Cancer & Development
436
Oncology
360
Noncoding RNA
211
Liver & Colon Cancer
201
Cancer, Autophagy & Apoptosis
188
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
14,008
Articles tracked across the journal lifetime
Indexed publication set
177
146 cited publications
Last 12 months
85
8.5 publications/month
Open access share
18.8%
16 OA publications in the last year
Leading citing country
China
527 citing publications
Leading citing field
Cancer & Development
436 citing publications
Latest tracked publication
9 October 2026
10 recent records available
Coverage & Indexing History
v1n1,Jan. 1980-
v1n1,Jan. 1980-
Active Coverage
Research Focus & Classification
Indexed Subjects
Cancer & Development
DNA Damage
Oncology
Immunology
Lung Cancer
Noncoding RNA
Liver & Colon Cancer
Broad Categories
Neoplasms
Noncoding RNA
Cancer, Autophagy & Apoptosis
Digestive Disorders
Immunology
Cancer & Development
Genetics & Genomics
MeSH Descriptors
Carcinogens
Medical Oncology
Mutagens
Neoplasms
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1093/carcin/bgag076
Open DOI
The Tumour Neurotone: neurochemical regulation of cancer progression and therapy
Neural regulation of cancer extends beyond anatomical innervation: tumours receive systemic neural and neuroendocrine inputs and locally produce and decode neurotransmitters and neuropeptides. We propose the Tumour Neurotone (TN) as a tu...
02
03
04
DOI 10.1093/carcin/bgag066
Open DOI
PHB2 Promotes Glycolytic Reprogramming in Triple-Negative Breast Cancer Through FOXM1-Dependent Activation of LDHB
Triple-negative breast cancer (TNBC) presents significant clinical challenges due to its aggressive phenotype and the limited availability of molecularly targeted therapies. In this study, we investigated the therapeutic potential of tar...
05
DOI 10.1093/carcin/bgag053
Open DOI
The emerging roles of non-coding RNAs in cancer
Non-coding RNAs (ncRNAs) regulate gene expression through transcriptional, post-transcriptional, and epigenetic mechanisms, shaping hallmarks of cancer, including metastasis, therapy resistance, and relapse. Carcinogenesis arises when ab...
06
DOI 10.1093/carcin/bgag046
Open DOI
Retraction of: HGF induces CXCR4 and CXCL12-mediated tumor invasion through Ets1 and NF-κB
07
08
DOI 10.1093/carcin/bgag050
Open DOI
The P2X7 Receptor in Cancer: From Functional Receptor to Non-Functional P2X7
The ATP-gated P2X7 receptors are abundantly expressed in immune cells, neurons, glial cells, and cancer cells. The P2X7 receptor performs distinct functions, depending on the extracellular ATP concentration and the duration of exposure t...
09
10
Bibliographical & Catalog Notes
Place of publication varies.
Available also online.
Vol. 9, no. 2 (FEB 1988)19930708 Notice published Printed on acid-free paper